University Health Network- Toronto General Hospital
Welcome,         Profile    Billing    Logout  
 10 Trials 
16 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Katz, Joel
NCT03986060 / 2019-000996-17: Shouldice Hospital Outcome Study

Recruiting
N/A
3000
Canada
York University
Inguinal Hernia
05/23
05/24
Cattran, Daniel
REBOOT, NCT03949855: Belimumab With Rituximab for Primary Membranous Nephropathy

Recruiting
2
58
Canada, US
Belimumab, Benlysta®, Placebo for Belimumab, Belimumab placebo, Rituximab, Rituxan®
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN), GlaxoSmithKline, PPD DEVELOPMENT, LP, Rho Federal Systems Division, Inc.
Membranous Nephropathy, Nephrotic Syndrome
03/29
03/30
NEPTUNE, NCT01209000: Nephrotic Syndrome Study Network

Recruiting
N/A
1200
Canada, US
Kidney Biopsy
University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The NephCure Foundation
Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental
06/26
06/26
TESTING-ON, NCT05434325: TESTING -ON Post-Trial ObservatioNal Cohort Study

Recruiting
N/A
366
Canada, RoW
The George Institute, Peking University Institute of Nephrology
IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases
07/27
07/27
Clarke, Hance
PLAN, NCT04874038: Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery

Recruiting
3
1602
Canada, RoW
Lidocaine 20mg/ml, Lidocaine 2%, Placebo, 0.9% sodium chloride solution
University Health Network, Toronto, Canadian Institutes of Health Research (CIHR)
Post-mastectomy Pain Syndrome, Breast Cancer, Pain, Postoperative, Pain, Chronic
06/25
06/26
MC-RWE, NCT04526093: Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis

Recruiting
N/A
1000
Canada
Medical Cannabis, Medical Marijuana
University Health Network, Toronto, Avicanna Inc
Pain, Sleep, Anxiety, Depression, Epilepsy
03/25
07/25
RECOUP, NCT03675386: Reducing Opioid Use for Chronic Pain Patients Following Surgery

Recruiting
N/A
210
Canada
Interventional Group, Transitional Pain Service Program, Control Intervention
University Health Network, Toronto
Chronic Pain, Opioid Use, Postoperative Pain, Opioid Dependence
05/24
05/24
NCT04885192: Implementation and Evaluation of a Stepped-Care Mental Health Treatment Program for Patients With Chronic Pain

Active, not recruiting
N/A
70
Canada
Stepped-Care Model, Psychological screening, Acceptance and Commitment Therapy, Dialectic Behavior Therapy
University Health Network, Toronto
Chronic Pain
09/24
12/24
NCT05351905: Improving Pain Disability With the Use of Oral Cannabinoids

Recruiting
N/A
51
Canada
CBD oil ( MPL-001), CBD concentrate, CDB+THC oil (MPL-005), Placebo oil, Matching placebo
University Health Network, Toronto
Chronic Pain, Opioid Use, Cannabis
05/24
12/24
CT-Pain, NCT04798573: Phenomics and Genomics of Clinically Relevant Chronic Postsurgical Pain

Active, not recruiting
N/A
10000
Canada
University Health Network, Toronto
Chronic Pain, Surgery
12/24
12/25
Rotstein, Coleman
MARIO, NCT05178862 / 2022-000648-32: A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Suspended
3
220
Europe, Canada, US, RoW
SCY-078, Ibrexafungerp, Fluconazole, Diflucan, Echinocandin, Caspofungin, Micafungin, Anidulafungin
Scynexis, Inc., SCYNEXIS, Inc.
Candidiasis, Invasive, Candidemia
06/24
08/24
Slepian, Maxwell
ADOPT-TPS, NCT06455345: Online Psychology Program for Chronic Pain After Surgery

Not yet recruiting
N/A
60
Canada
Self-Guided Online ACT Program, Treatment As Usual, Psychologist-guided online ACT
University Health Network, Toronto, Academic Medical Organization of Southwestern Ontario, York University, Toronto General Hospital
Post-surgical Pain, Pain, Acute, Pain, Chronic, Post-Surgical Pain, Chronic
04/25
04/26
Mittal, Nimish
NCT05652907: Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)

Terminated
2
2
Canada, US
FSD201, Placebo
FSD Pharma, Inc.
Mast Cell Activation Syndrome, Mast Cell Activation Disorder Idiopathic
05/23
05/23
NCT05366114: Vision-based Assessment of Joint Extensibility in Ehlers Danlos Syndrome

Enrolling by invitation
N/A
225
Canada
No intervention, additional video data collection only
University Health Network, Toronto
Ehlers-Danlos Syndrome
06/24
12/24
NCT05434728: Characterization of Bleeding Disorders in EDS

Enrolling by invitation
N/A
45
Canada
20 ml venous blood collection
University Health Network, Toronto
Ehlers-Danlos Syndrome, EDS, Classical Ehlers-Danlos Syndrome, Classical EDS (cEDS), Hypermobile Ehlers-Danlos Syndrome, Hypermobile EDS (hEDS), Vascular Ehlers-Danlos Syndrome, Vascular EDS (vEDS)
12/23
02/24
Obaseki, Melody
MARIO, NCT05178862 / 2022-000648-32: A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Suspended
3
220
Europe, Canada, US, RoW
SCY-078, Ibrexafungerp, Fluconazole, Diflucan, Echinocandin, Caspofungin, Micafungin, Anidulafungin
Scynexis, Inc., SCYNEXIS, Inc.
Candidiasis, Invasive, Candidemia
06/24
08/24

Download Options